Invenomic Capital Management LP SSYS STRATASYS LTD

Ownership history in Invenomic Capital Management LP  ·  7 quarters on record

AI Ownership Summary

Invenomic Capital Management LP reported STRATASYS LTD (SSYS) in 7 quarterly 13F filings from 2024 Q3 through 2026 Q1. Peak portfolio weight reached 1.74% in 2025 Q2. The latest visible filing shows SSYS at 0.73% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this SSYS ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Invenomic Capital Management LP's position in STRATASYS LTD, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

SSYS was reported at 0.73% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.74% in 2025 Q2

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How Invenomic Capital Management LP held SSYS — position size vs. price
% of Fund (quarterly)    SSYS price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 REDUCED 2,037,384 -90,226 -4.2% 0.73% $15.9M 2026-05-15 $8.56
2025 Q4 REDUCED 2,127,610 -6,423 -0.3% 0.86% $18.5M 2026-02-17 $10.67
2025 Q3 REDUCED 20.1% -21.3% 2,134,033 -536,540 -20.1% 1.16% $23.9M 2025-11-14 $8.95
2025 Q2 ADDED 2,670,573 +204,375 +8.3% 1.74% $30.6M 2025-08-14 $9.22
2025 Q1 ADDED 2,466,198 +1,302,264 +111.9% 1.22% $24.1M 2025-05-15 $11.06
2024 Q4 REDUCED 11.4% +10.1% 1,163,934 -149,636 -11.4% 0.49% $10.3M 2025-02-14 $11.99
2024 Q3 INITIATED 1,313,570 0.60% $10.9M 2024-11-14 $9.61

FAQ About Invenomic Capital Management LP and SSYS

These are the practical questions this page is built to answer before you even open the full history table.

How long has Invenomic Capital Management LP reported owning SSYS?

Invenomic Capital Management LP reported SSYS across 7 quarterly 13F filings, from 2024 Q3 through 2026 Q1.

What was the largest reported SSYS position in Invenomic Capital Management LP's portfolio?

The largest reported portfolio weight for SSYS was 1.74% in 2025 Q2.

What is the latest reported SSYS position on this page?

The most recent filing on this page is 2026 Q1, when Invenomic Capital Management LP reported 2,037,384 shares, equal to 0.73% of portfolio, with an estimated market value of $15.9M.

What does the chart on this SSYS ownership page compare?

The chart compares Invenomic Capital Management LP's quarterly SSYS portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Invenomic Capital Management LP time their SSYS position?

Based on 13F filing dates vs. subsequent SSYS price moves, Invenomic Capital Management LP correctly timed 3 out of 6 reported position changes (50%). The annualised alpha on SSYS relative to SPY over the holding period was -21.0%.

← Back to Invenomic Capital Management LP Holdings